Medical News

RSS

Biogen, Elan launch My MS Health, a web-based PRO research program

Biogen Idec and Elan Corporation, plc, in collaboration with EPI-Q, Inc. and Avatar International, LLC, today announced the launch of My MS Health, a first-of-its-kind, web-based, patient-reported outcomes research program. My MS Health is designed to track and provide instant reports on patient function and quality of life using validated measures over time.

9 Jun 2010

Gates Foundation announces 5-year, $1.5 billion commitment for maternal, child health

During the Women Deliver conference on Monday Melinda Gates announced that the Bill & Melinda Gates Foundation "will spend $1.5 billion over the next five years on maternal and child health, family planning and nutrition in developing countries, a pledge that signals a new focus for the foundation known for concentrating on vaccines and AIDS," the Wall Street Journal reports (Jordan, 6/7).

9 Jun 2010

American Diversified Holdings enters Mobile Health Care Market

American Diversified Holdings Corporation has today announced its intention to enter the Mobile Health Care Market as the medical profession gears up to go electronic not only for medical records but also for direct patient monitoring and information.

9 Jun 2010

Inquiry into the hospital acquired killer bug starts

A Second World War veteran John Boyle died of Clostridium difficile infection after being admitted to hospital for the first time at the age of 90. He was diagnosed with the infection on January 25 this year and succumbed to it two weeks later. He was one of 18 patients to die at a Scottish hospital when the outbreak of this hospital-acquired infection was reported.

8 Jun 2010

Waste incinerator spewing chemical waste: Says worried Brisbane Lord Mayor

A council commissioned study into the Ace Waste incinerator at Willawong showed that the residents and businesses around the facility were at potential risk of exposure to chemical emissions. The incinerator at Willawong is used to dispose of medical and chemical pollutants that can cause cancer when people are exposed to high concentrations. Brisbane Lord Mayor Campbell Newman revealed this last night. Premier Anna Bligh however denies that there is such a risk. She has assured that the incinerator is safe and there have been no problems for the past twenty year.

8 Jun 2010

Finished school – better health for Indigenous Australians

A new report prepared by the Australian Bureau of Statistics (ABS) has found that indigenous Australians who go on to complete their school education fare much better health wise than those who do not.

8 Jun 2010

USTPO awards Melior Discovery Notice of Allowance for type II diabetes and obesity drug candidate

Melior Discovery, Inc. announced today the United States Patent and Trademark Office (USTPO) has awarded a Notice of Allowance for a broad patent application covering the Company's use of MLR-1023 for, among other things, the treatment of type II diabetes and obesity. The patent will cover use of MLR-1023 for the treatment of type II diabetes, obesity and metabolic syndrome, including its use in combination with other compounds and as a component in other drugs.

8 Jun 2010

Argos presents positive AGS-003 Phase 2 data for newly diagnosed advanced renal cell carcinoma at ASCO

Argos Therapeutics today announced the presentation of positive interim data from a Phase 2 trial that evaluated the clinical activity, safety and immune response of AGS-003 treatment, given in combination with sunitinib, in patients with newly diagnosed advanced renal cell carcinoma (RCC). The data were discussed June 7 in a poster session at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, IL.

8 Jun 2010

America's Minority Health Network signs LOI to acquire Spectrum Health Network

AMHN, Inc., announced today that it entered into a Letter of Intent ("LOI") with Gordon Communications, Inc., a Delaware corporation, to acquire Spectrum Health Network, Inc. ("Spectrum"). Spectrum is a digital signage waiting room network built for the multi-specialty group practice and independent physician associations.

8 Jun 2010

NanoViricides anti-HIV drug candidates demonstrate efficacy in cell culture studies with HIV-1 isolates

NanoViricides, Inc. reports that its anti-HIV drug candidates demonstrated efficacy in the recently completed cell culture studies using two distinctly different HIV-1 isolates. The studies were performed in the laboratory of Carol Lackman-Smith at the Southern Research Institute, Frederick, Maryland.

8 Jun 2010

Immunomedics reports encouraging results from TF2 Phase I studies for colorectal cancer

Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported that TF2, a proprietary bispecific antibody, has shown selective tumor localization and minimal normal tissue retention in two early Phase I studies in patients with colorectal cancer.

8 Jun 2010

HPV-positive tumor status is strong prognostic factor for head, neck cancer

Oropharyngeal cancer patients whose tumors in the upper part of the throat test positively for the human papillomavirus (HPV) have better overall survival than patients with HPV-negative disease, researchers from The University of Texas MD Anderson Cancer Center report in a study published in The New England Journal of Medicine.

8 Jun 2010

Princeton University president named 2010 winner of Henry G. Friesen International Prize in Health Research

Internationally renowned scientist and scholar Shirley M. Tilghman, president of Princeton University, was named the 2010 winner of the Henry G. Friesen International Prize in Health Research.

8 Jun 2010

Successive 12-hour shifts for hospital nurses leads to widespread fatigue, patient care errors

A common practice of successive 12-hour shifts for U.S. hospital nurses leaves many with serious sleep deprivation, higher risk of health problems, and more odds of making patient errors, according to a University of Maryland, Baltimore (UMB) study presented today at the 24th annual meeting of the Associated Professional Sleep Societies in San Antonio.

8 Jun 2010

NexGen Biomedical offers RNAi / PSR platform technology for sale

NexGen Biomedical, Inc. announced today that it is offering its RNAi / PSR platform technology for sale. "While technologies like siRNA are well suited for disease conditions involving expression of a single protein, the RNAi / PSR technology is better suited for conditions involving expression of a broad spectrum of proteins such as happens with cell hyperproliferation, inflammation, and viral infections.

8 Jun 2010

Researchers find LEB or EV demonstrates faster rate of healing for larger wounds

Researchers from Georgetown University Hospital in Washington, DC have found that wound healing after lower extremity bypass or endovascular revascularization demonstrated a more complete and faster rate of healing for larger wounds of more than 2 cm after open bypass. Findings will be presented at the 64th Vascular Annual Meeting presented by the Society for Vascular Surgery, June 10 in Boston.

8 Jun 2010

Aerovance reports top-line results from Aerovant Phase 2b clinical trial for eosinophilic asthma

Aerovance Inc. today announced top-line results from its Phase 2b clinical trial that show the inhaled dry powder formulation of Aerovant (pitrakinra inhalation powder) is effective in a pre-defined subset of patients with eosinophilic asthma.

8 Jun 2010

Breast cancer research showcased at ASCO Annual Meeting

Canadian Breast Cancer Foundation funded research will be presented today at the 2010 American Society of Clinical Oncology Annual Meeting in Chicago.

8 Jun 2010

Health Canada approves Novartis' Menveo for prevention of meningococcal disease

Novartis Pharmaceutical Canada Inc. announced that Menveo (Meningococcal (Groups A, C, Y and W-135) Oligosaccharide CRM197 Conjugate Vaccine), a quadrivalent meningococcal conjugate vaccine was approved by Health Canada for active immunization of adolescents (11 to 18 years of age) and adults (19 to 55 years of age) to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135.

8 Jun 2010

Prime Outlets join forces with American Cancer Society to promote Choose You movement

Prime Outlets, a portfolio of 21 outlet shopping destinations across the U.S., announced today it has joined forces with the American Cancer Society to promote the organization's Choose You movement, a campaign to help motivate women to prioritize their health and engage in lifestyle behaviors that can help reduce their cancer risk.

8 Jun 2010

Medical News

Biogen, Elan launch My MS Health, a web-based PRO research program

Gates Foundation announces 5-year, $1.5 billion commitment for maternal, child health

American Diversified Holdings enters Mobile Health Care Market

Inquiry into the hospital acquired killer bug starts

Waste incinerator spewing chemical waste: Says worried Brisbane Lord Mayor

Finished school – better health for Indigenous Australians

USTPO awards Melior Discovery Notice of Allowance for type II diabetes and obesity drug candidate

Argos presents positive AGS-003 Phase 2 data for newly diagnosed advanced renal cell carcinoma at ASCO

America's Minority Health Network signs LOI to acquire Spectrum Health Network

NanoViricides anti-HIV drug candidates demonstrate efficacy in cell culture studies with HIV-1 isolates

Immunomedics reports encouraging results from TF2 Phase I studies for colorectal cancer

HPV-positive tumor status is strong prognostic factor for head, neck cancer

Princeton University president named 2010 winner of Henry G. Friesen International Prize in Health Research

Successive 12-hour shifts for hospital nurses leads to widespread fatigue, patient care errors

NexGen Biomedical offers RNAi / PSR platform technology for sale

Researchers find LEB or EV demonstrates faster rate of healing for larger wounds

Aerovance reports top-line results from Aerovant Phase 2b clinical trial for eosinophilic asthma

Breast cancer research showcased at ASCO Annual Meeting

Health Canada approves Novartis' Menveo for prevention of meningococcal disease

Prime Outlets join forces with American Cancer Society to promote Choose You movement

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News